| Financial Year |
March 31 2023 |
| Monetary Funds |
199,062,912.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,000,000.00 |
| Accounts Receivable |
222,538,803.99 |
| Advances to Suppliers |
721,817.31 |
| Other Receivables |
34,335,027.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
68,506,909.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
736,887.91 |
| Other Current Assets |
157,901,607.11 |
| Total Current Assets |
1,122,397,203.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,150,424,227.24 |
| Long-term Equity Investment |
16,327,118.17 |
| Investment Properties |
11,076,482.23 |
| Fixed Assetes |
14,968,500.05 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
73,270.38 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,128,157.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,648,158.35 |
| Deferred Income Tax Assets |
43,570,968.53 |
| Other Non-Current Assets |
426,441,873.64 |
| Sub-Total of Non-Current Assets |
1,677,788,411.23 |
| Total Assets |
2,800,185,614.36 |
| Short-Term Loans |
555,253,825.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,976,672.22 |
| Accounts Payable |
693,637,071.46 |
| Accounts Received In Advance |
775,113.19 |
| Employee Compensation Payable |
3,291,907.52 |
| Taxes Payable |
10,375,531.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
83,553,313.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,560,406.14 |
| Other Current Liabilities |
310,648,441.70 |
| Sub-Total of Current Liabilities |
1,724,191,376.72 |
| Long-term Loans |
670,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
22,196,113.67 |
| Deferred Income Tax Liabilities |
2,310,356.11 |
| Other Non-Current Liabilities |
63,851,454.69 |
| Sub-Total of Non-Current Liabilities |
764,980,640.84 |
| Total Liabilities |
2,489,172,017.56 |
| Paid-In Capital(Or Share Stock) |
184,132,890.00 |
| Capital Surplus |
787,050,536.32 |
| Surplus Reserve |
41,424,177.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-961,032,867.56 |
| Minority Stockholder's Interest |
258,162,100.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
52,851,496.26 |
| Owner's Equity（Stockholder's Equity） |
311,013,596.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,800,185,614.36 |
